Skip to content
Search

Latest Stories

Invatech Health completes £2.2 million funding for pharmacy software Titan

Invatech Health has secured an award of £900,000 from Innovate UK for its cutting-edge pharmacy software Titan.

The latest round of funding takes the total amount the Bristol-based firm received under a competitive programme to support SME innovations to £2.2 million.


“Innovate UK is pleased to support Invatech Health in its important and highly innovative development of Titan PMR for the pharmacy sector,” commented Nigel Walker, deputy director at Innovate UK, which is part of the national funding agency UK Research and Innovation.

“The business has met all the objectives established during the first phase of the loan arrangement and we are delighted to provide further funding to support the company’s ongoing innovations.”

Invatech received an initial loan in February 2018 for the development of Titan, which is complemented by further grant funding during the Covid-19 pandemic to support remote working for independent pharmacists.

Tariq Muhammad, chief executive of Invatech Health, said the latest funding will support the development of new features for the company’s leading platform.

“With this additional support from Innovate UK we plan to develop a wide range of new game-changing apps, delivered as extensions on the Titan platform,” he said. “These will help address the new and immediate challenges that pharmacies are facing as a result of Covid-19 and provide innovative solutions to support their businesses and their patients in the long term.”

Muhammad added that the pandemic has shone light on the shortcomings of old technology across the sector, among large online businesses and small independents alike.

“This crisis has highlighted the incapacity of legacy systems to scale up and adapt to dynamic situations, in many business sectors,” he commented.

“The pandemic has put pharmacies are under significant pressure and there is a need for technology that can help them cope with greater volume of work, as well as releasing pharmacists time to spend on frontline healthcare.”

A cloud-based solution, Titan digitises the end-to-end workflow within pharmacies, makes medicine dispensing safer using barcode technology, helps control business activities and improves the experience for patients and practice owners alike, freeing up pharmacists’ time in the process to help them focus on newly-commissioned patient services designed to relieve the burden from under-pressure GPs and the wider NHS.

The solution became the first pharmacy Patient Medication Record (PMR) to get accredited by NHS in one and a half decade, and since the feat in late 2019, it has cornered two per cent market share, processing over 1.5 million prescriptions per month.

The technology has also become the platform of choice for some of the largest UK online pharmacies which have leveraged its highly scalable cloud infrastructure to process mass volumes and, in some cases, over 60,000 prescriptions per day.

“We’re delighted with the progress that Titan has made, commercially and operationally, over the past two years. We have taken an idea and built something which is helping independent pharmacy businesses and large scale operators alike,” Muhammad said.

“With 5,000 independent and small group pharmacists in England and Wales, alongside the larger corporates, the commercial potential for Titan is massive. We’re fundamentally different to all other PMRs and are offering a new way of life for pharmacists and a new way of doing things.”

More For You

NHS to roll out RSV vaccinations across 200 pharmacies in 2025/26

NHS England aims to ensure that everyone aged 75 to 79 years old is offered RSV vaccination by 31 August 2025.

Photo credit: gettyimages

RSV vaccination pilot to expand to 200 pharmacies in 2025/26

As part of its public health functions for 2025/26, NHS England plans to expand the Respiratory Syncytial Virus (RSV) immunisation programme to include up to 200 community pharmacies in targeted areas.

This follows the launch of an early adopter initiative in September 2024, where 50 community pharmacy sites in the East of England were commissioned to offer RSV vaccinations.

Keep ReadingShow less
RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less